Neurosteroids Shift Partial Agonist Activation of GABA(A) Receptor Channels from Low- to High-efficacy Gating Patterns

Overview

Journal J Neurosci

Specialty Neurology

Date 2003 Dec 4

PMID 14645489

Citations 117

Authors

Matt T Bianchi

Robert L Macdonald

Affiliations

Soon will be listed here.

Abstract

Although GABA activates synaptic (alphabetagamma) GABA(A) receptors with high efficacy, partial agonist activation of alphabetagamma isoforms and GABA activation of the primary extrasynaptic (alphabetadelta) GABA(A) receptors are limited to low-efficacy activity, characterized by minimal desensitization and brief openings. The unusual sensitivity of alphabetadelta receptor channels to neurosteroid modulation prompted investigation of whether this high sensitivity was dependent on the delta subunit or the low-efficacy channel function that it confers. We show that the isoform specificity (alphabetadelta > alphabetagamma) of neurosteroid modulation could be reversed by conditions that reversed isoform-specific activity modes, including the use of beta-alanine to achieve increased efficacy with alphabetadelta receptors and taurine to render alphabetagamma receptors low efficacy. We suggest that neurosteroids preferentially enhance low-efficacy GABA(A) receptor activity independent of subunit composition. Allosteric conversion of partial to full agonism may be a general mechanism for reversibly scaling the efficacy of GABA(A) receptors to endogenous partial agonists.

Citing Articles

Functional Food Nutrients, Redox Resilience Signaling and Neurosteroids for Brain Health.

Scuto M, Majzunova M, Torcitto G, Antonuzzo S, Rampulla F, Di Fatta E Int J Mol Sci. 2024; 25(22).

PMID: 39596221 PMC: 11594618. DOI: 10.3390/ijms252212155.

Unraveling the gut-brain axis: the impact of steroid hormones and nutrition on Parkinson's disease.

Neufeld P, Nettersheim R, Matschke V, Vorgerd M, Stahlke S, Theiss C Neural Regen Res. 2024; 19(10):2219-2228.

PMID: 38488556 PMC: 11034592. DOI: 10.4103/1673-5374.391304.

GABA receptors as plausible molecular targets and mediators for taurine and homotaurine actions.

Meera P, Uusi-Oukari M, Lipshutz G, Wallner M Front Pharmacol. 2023; 14:1271203.

PMID: 38155909 PMC: 10752957. DOI: 10.3389/fphar.2023.1271203.

Neurosteroids: mechanistic considerations and clinical prospects.

Maguire J, Mennerick S Neuropsychopharmacology. 2023; 49(1):73-82.

PMID: 37369775 PMC: 10700537. DOI: 10.1038/s41386-023-01626-z.

Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder.

Cutler A, Mattingly G, Maletic V Transl Psychiatry. 2023; 13(1):228.

PMID: 37365161 PMC: 10293235. DOI: 10.1038/s41398-023-02514-2.

References

Mehta A, Ticku M . An update on GABAA receptors. Brain Res Brain Res Rev. 1999; 29(2-3):196-217. DOI: 10.1016/s0165-0173(98)00052-6. View

Thompson S, Arden S, Marshall G, Wingrove P, Whiting P, Wafford K . Residues in transmembrane domains I and II determine gamma-aminobutyric acid type AA receptor subtype-selective antagonism by furosemide. Mol Pharmacol. 1999; 55(6):993-9. DOI: 10.1124/mol.55.6.993. View

Halliwell R, Thomas P, Patten D, James C, Martinez-Torres A, Miledi R . Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid. Eur J Neurosci. 1999; 11(8):2897-905. DOI: 10.1046/j.1460-9568.1999.00709.x. View

Khakh B, Proctor W, Dunwiddie T, Labarca C, Lester H . Allosteric control of gating and kinetics at P2X(4) receptor channels. J Neurosci. 1999; 19(17):7289-99. PMC: 6782529. View

Mihalek R, Banerjee P, Korpi E, Quinlan J, Firestone L, Mi Z . Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci U S A. 1999; 96(22):12905-10. PMC: 23157. DOI: 10.1073/pnas.96.22.12905. View

Rudolph U, Crestani F, Benke D, Brunig I, Benson J, Fritschy J . Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature. 1999; 401(6755):796-800. DOI: 10.1038/44579. View

Cooper E, Johnston G, Edwards F . Effects of a naturally occurring neurosteroid on GABAA IPSCs during development in rat hippocampal or cerebellar slices. J Physiol. 1999; 521 Pt 2:437-49. PMC: 2269661. DOI: 10.1111/j.1469-7793.1999.00437.x. View

OShea S, Wong L, Harrison N . Propofol increases agonist efficacy at the GABA(A) receptor. Brain Res. 2000; 852(2):344-8. DOI: 10.1016/s0006-8993(99)02151-4. View

Fancsik A, Linn D, Tasker J . Neurosteroid modulation of GABA IPSCs is phosphorylation dependent. J Neurosci. 2000; 20(9):3067-75. PMC: 6773128. View

10.

Maksay G, Thompson S, Wafford K . Allosteric modulators affect the efficacy of partial agonists for recombinant GABA(A) receptors. Br J Pharmacol. 2000; 129(8):1794-800. PMC: 1572013. DOI: 10.1038/sj.bjp.0703259. View

11.

McKernan R, Rosahl T, Reynolds D, Sur C, Wafford K, Atack J . Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci. 2000; 3(6):587-92. DOI: 10.1038/75761. View

12.

Wang H, Ohno K, Milone M, Brengman J, Evoli A, Batocchi A . Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome. J Gen Physiol. 2000; 116(3):449-62. PMC: 2233692. DOI: 10.1085/jgp.116.3.449. View

13.

Low K, Crestani F, Keist R, Benke D, Brunig I, Benson J . Molecular and neuronal substrate for the selective attenuation of anxiety. Science. 2000; 290(5489):131-4. DOI: 10.1126/science.290.5489.131. View

14.

Bai D, Zhu G, Pennefather P, Jackson M, MacDonald J, Orser B . Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by gamma-aminobutyric acid(A) receptors in hippocampal neurons. Mol Pharmacol. 2001; 59(4):814-24. DOI: 10.1124/mol.59.4.814. View

15.

Herlitze S, Zhong H, Scheuer T, Catterall W . Allosteric modulation of Ca2+ channels by G proteins, voltage-dependent facilitation, protein kinase C, and Ca(v)beta subunits. Proc Natl Acad Sci U S A. 2001; 98(8):4699-704. PMC: 31897. DOI: 10.1073/pnas.051628998. View

16.

Zhong H, Li B, Scheuer T, Catterall W . Control of gating mode by a single amino acid residue in transmembrane segment IS3 of the N-type Ca2+ channel. Proc Natl Acad Sci U S A. 2001; 98(8):4705-9. PMC: 31898. DOI: 10.1073/pnas.051629098. View

17.

Brickley S, Revilla V, Cull-Candy S, Wisden W, Farrant M . Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature. 2001; 409(6816):88-92. DOI: 10.1038/35051086. View

18.

Adkins C, Pillai G, Kerby J, Bonnert T, Haldon C, McKernan R . alpha4beta3delta GABA(A) receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential. J Biol Chem. 2001; 276(42):38934-9. DOI: 10.1074/jbc.M104318200. View

19.

Bianchi M, Macdonald R . Mutation of the 9' leucine in the GABA(A) receptor gamma2L subunit produces an apparent decrease in desensitization by stabilizing open states without altering desensitized states. Neuropharmacology. 2001; 41(6):737-44. DOI: 10.1016/s0028-3908(01)00132-0. View

20.

Steinbach J, Akk G . Modulation of GABA(A) receptor channel gating by pentobarbital. J Physiol. 2001; 537(Pt 3):715-33. PMC: 2278986. DOI: 10.1111/j.1469-7793.2001.00715.x. View